Indaptus Therapeutics (INDP) Shares Outstanding (Entity) (2020 - 2026)
Indaptus Therapeutics' Shares Outstanding (Entity) was 64.11 million in Q2 2026, compared with 574,923 a year earlier and up 485.1% from the prior quarter.
Indaptus Therapeutics (INDP) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at Indaptus Therapeutics came in at 966,124, up 189.2% from FY2024.
- Shares Outstanding (Entity) shows a five-year compound annual growth rate of 69.3% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Entity) was 334,092 in FY2024 (+11.4%), 300,001 in FY2023 (unchanged), 300,001 in FY2022 (+105.4%) and 146,075 in FY2021 (+110.3%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2020.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.0% (Q4 2023) and 344.3% (Q2 2022) over the last five years.
- Per Business Quant data, INDP's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 10.96 million (Q1 2026), 966,124 (Q4 2025) and 997,038 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Indaptus Therapeutics | 147.46 Mn | 120.07 Mn | - | 64.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.11 Mn |
| Mar 31, 2026 | 10.96 Mn |
| Dec 31, 2025 | 966,124.00 |
| Sep 30, 2025 | 997,038.00 |
| Jun 30, 2025 | 574,923.00 |
| Mar 31, 2025 | 572,590.00 |
| Dec 31, 2024 | 334,092.00 |
| Sep 30, 2024 | 364,131.00 |
| Jun 30, 2024 | 305,429.00 |
| Mar 31, 2024 | 304,924.00 |
| Dec 31, 2023 | 300,001.00 |
| Sep 30, 2023 | 300,001.00 |
| Jun 30, 2023 | 300,001.00 |
| Mar 31, 2023 | 300,001.00 |
| Dec 31, 2022 | 300,001.00 |
| Sep 30, 2022 | 294,914.00 |
| Jun 30, 2022 | 294,914.00 |
| Mar 31, 2022 | 294,914.00 |
| Dec 31, 2021 | 146,075.00 |
| Sep 30, 2021 | 149,294.00 |
Indaptus Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=INDP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();